A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
CONCLUSIONS: This new risk stratification model for systemic lupus erythematosus-associated pulmonary arterial hypertension may provide individualized prognostic probability using readily obtained clinical risk factors. External validation is required to demonstrate the accuracy of this model's predictions in diverse patient populations.PMID:37689662 | DOI:10.1186/s12931-023-02522-2
Source: Respiratory Care - Category: Respiratory Medicine Authors: Jingge Qu Mengtao Li Xiao Zhang Miaojia Zhang Xiaoxia Zuo Ping Zhu Shuang Ye Wei Zhang Yi Zheng Wufang Qi Yang Li Zhuoli Zhang Feng Ding Jieruo Gu Yi Liu Junyan Qian Can Huang Jiuliang Zhao Qian Wang Yongtai Liu Zhuang Tian Yanhong Wang Wei Wei Xiaofeng Z Source Type: research
More News: Bilirubin | Brain | Hypertension | International Medicine & Public Health | Interstitial Lung Disease | Lupus | Men | Neurology | Respiratory Medicine | Study | Thrombocytopenia | WHO